Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The …
Over the last 12 months, insiders at Helius Medical Technologies, Inc. have bought $0 and sold $0 worth of Helius Medical Technologies, Inc. stock.
On average, over the past 5 years, insiders at Helius Medical Technologies, Inc. have bought $339,212 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $40,475 was made by ANDREEFF DANE (President and CEO) on 2023‑12‑14.
2023-12-14 | President and CEO | 5,000 0.7564% | $8.10 | $40,475 | -81.67% | |||
2023-12-01 | President and CEO | 643 0.0932% | $6.45 | $4,146 | -72.93% | |||
2023-11-30 | President and CEO | 641 0.0922% | $6.37 | $4,083 | -72.08% | |||
2023-08-30 | President and CEO | 5,000 0.878% | $7.64 | $38,212 | -23.01% | |||
2023-08-28 | President and CEO | 5,078 0.8791% | $6.37 | $32,339 | -5.54% | |||
2022-12-16 | President and CEO | 80,041 0.2864% | $0.25 | $19,946 | -25.30% | |||
2022-11-23 | President and CEO | 85,640 0.2869% | $0.31 | $26,694 | -42.42% | |||
2022-11-22 | President and CEO | 10,300 0.0343% | $0.28 | $2,919 | -37.09% | |||
2022-11-17 | President and CEO | 106,541 0.3654% | $0.34 | $36,064 | -45.43% | |||
2022-11-16 | President and CEO | 10,000 0.0369% | $0.32 | $3,224 | -38.39% | |||
2022-08-24 | President and CEO | 23,937 0.2642% | $0.63 | $15,080 | -62.57% | |||
2021-12-17 | President and CEO | 5,100 0.1671% | $5.25 | $26,789 | -72.27% | |||
2021-12-17 | CFO and Treasurer | 3,000 0.0994% | $5.31 | $15,929 | -72.27% | |||
2021-11-12 | President and CEO | 37,500 1.1813% | $8.00 | $300,000 | -75.34% | |||
2021-09-15 | President and CEO | 10,000 0.4391% | $14.72 | $147,222 | -76.75% | |||
2021-09-10 | President and CEO | 10,000 0.4316% | $14.96 | $149,629 | -76.64% | |||
2021-09-08 | President and CEO | 6,000 0.2574% | $14.83 | $88,957 | -76.46% | |||
2021-09-07 | President and CEO | 4,450 0.1935% | $14.86 | $66,139 | -75.94% | |||
2020-05-15 | director | 200,000 0.5524% | $0.56 | $112,000 | -13.31% | |||
2020-05-14 | director | 100,000 0.2631% | $0.56 | $56,000 | -17.42% |
Deschamps Philippe | President and CEO | 3334556 89.4422% | $0.86 | 1 | 0 | |
Walter Blane | director | 422653 11.3367% | $0.86 | 3 | 0 | |
LaViscount Joyce N | CFO and COO | 129306 3.4684% | $0.86 | 1 | 0 | |
ANDREEFF DANE | President and CEO | 16512 0.4429% | $0.86 | 27 | 0 | <0.0001% |
STRAW EDWARD M | director | 12500 0.3353% | $0.86 | 1 | 0 |